Metformin inhibits small intestinal neuroendocrine tumor growth in vivo - Top-Institutions - MDSpire

Metformin inhibits small intestinal neuroendocrine tumor growth in vivo

  • By

  • Fredrik Axling

  • Samuel Backman

  • Per Hellman

  • Olov Norlén

  • Elham Barazeghi

  • Peter Stålberg

  • June 25, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Uppsala University
    Uppsala University

    Uppsala, Uppsala County

    Key Differentiators

    • Oncology

  • #2

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Oncology

  • #3

    Sahlgrenska Cancer Center, University of Gothenburg
    Sahlgrenska Cancer Center, University of Gothenburg

    Gothenburg, Västra Götaland County

    Key Differentiators

    • Oncology

  • #4

    Karolinska Institutet
    Karolinska Institutet

    Solna, Stockholm County

    Key Differentiators

    • Oncology

  • #5

    Seoul National University
    Seoul National University

    Seoul, Seoul

    Key Differentiators

    • Oncology

Original Source(s)

Metformin inhibits small intestinal neuroendocrine tumor growth in vivo

  • by Fredrik Axling, Samuel Backman, Per Hellman, Olov Norlén, Elham Barazeghi, Peter Stålberg

  • June 25, 2026

Related Content

Severe asparaginase-associated hypertriglyceridemia in pediatric acute lymphoblastic leukemia: a single-center experience

Expression patterns of carbonic anhydrase IX and immune response biomarkers in pediatric gliomas and glioneuronal tumors

Mucosal-associated invariant T cells promote PDAC progression via TL1A–CSF-1 axis